Sterling Urgent Care opens its 6th location in the Treasure Valley, giving people in Boise a better choice for healthcare ...
Growing Importance of Healthcare and Laboratory LabelsThe healthcare and laboratory Labels Market sectors are becoming ...
The endoscopy devices market is experiencing a transformative phase, significantly driven by technological advancements that ...
Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production
Company Intends to Bring First Functional Mushroom Producer to RetailLAS VEGAS, NV / ACCESSWIRE / October 7, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the ...
Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest innovations enabling the ...
LAS VEGAS, NV, October 7, 2024 (Newswire.com) - Nitches, Inc. (OTC:NICH) proudly announces the upcoming launch of its new partner, business vertical and ecommerce website, unveiling a premium ...
Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab) Cambridge, UK – 10 October 2024: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral ...
Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), is pleased to announce that Paolo ...
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
At least two million doses of long-acting cabotegravir for PrEP to be made available in 2025-2026 to meet growing demand where HIV burden and unmet need are greatestStrong progress made with generic ...
Transgene will present median 24-month follow up data from patients enrolled in the Phase I trial evaluating the individualized cancer vaccine TG4050 in the adjuvant treatment of head and neck ...
Galapagos NV (Euronext & NASDAQ: GLPG), today announced the appointment by way of co-optation of Oleg Nodelman as Non-Executive Non-Independent Director to its Board of Directors, effective October 7, ...
The annual conference will be attended by Team ViroCell, including its newly appointed VP of Corporate Development and Strategy, Nicholas Ostrout PhD London, UK, New York, US, 7 October 2024 – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback